Cargando…
Vaccine-Derived Polioviruses, Central African Republic, 2019
Since May 2019, the Central African Republic has experienced a poliomyelitis outbreak caused by type 2 vaccine-derived polioviruses (VDPV-2s). The outbreak affected Bangui, the capital city, and 10 districts across the country. The outbreak resulted from several independent emergence events of VDPV-...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853572/ https://www.ncbi.nlm.nih.gov/pubmed/33496226 http://dx.doi.org/10.3201/eid2702.203173 |
_version_ | 1783645990356516864 |
---|---|
author | Joffret, Marie-Line Doté, Joël Wilfried Gumede, Nicksy Vignuzzi, Marco Bessaud, Maël Gouandjika-Vasilache, Ionela |
author_facet | Joffret, Marie-Line Doté, Joël Wilfried Gumede, Nicksy Vignuzzi, Marco Bessaud, Maël Gouandjika-Vasilache, Ionela |
author_sort | Joffret, Marie-Line |
collection | PubMed |
description | Since May 2019, the Central African Republic has experienced a poliomyelitis outbreak caused by type 2 vaccine-derived polioviruses (VDPV-2s). The outbreak affected Bangui, the capital city, and 10 districts across the country. The outbreak resulted from several independent emergence events of VDPV-2s featuring recombinant genomes with complex mosaic genomes. The low number of mutations (<20) in the viral capsid protein 1–encoding region compared with the vaccine strain suggests that VDPV-2 had been circulating for a relatively short time (probably <3 years) before being isolated. Environmental surveillance, which relies on a limited number of sampling sites in the Central African Republic and does not cover the whole country, failed to detect the circulation of VDPV-2s before some had induced poliomyelitis in children. |
format | Online Article Text |
id | pubmed-7853572 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-78535722021-02-09 Vaccine-Derived Polioviruses, Central African Republic, 2019 Joffret, Marie-Line Doté, Joël Wilfried Gumede, Nicksy Vignuzzi, Marco Bessaud, Maël Gouandjika-Vasilache, Ionela Emerg Infect Dis Dispatch Since May 2019, the Central African Republic has experienced a poliomyelitis outbreak caused by type 2 vaccine-derived polioviruses (VDPV-2s). The outbreak affected Bangui, the capital city, and 10 districts across the country. The outbreak resulted from several independent emergence events of VDPV-2s featuring recombinant genomes with complex mosaic genomes. The low number of mutations (<20) in the viral capsid protein 1–encoding region compared with the vaccine strain suggests that VDPV-2 had been circulating for a relatively short time (probably <3 years) before being isolated. Environmental surveillance, which relies on a limited number of sampling sites in the Central African Republic and does not cover the whole country, failed to detect the circulation of VDPV-2s before some had induced poliomyelitis in children. Centers for Disease Control and Prevention 2021-02 /pmc/articles/PMC7853572/ /pubmed/33496226 http://dx.doi.org/10.3201/eid2702.203173 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Dispatch Joffret, Marie-Line Doté, Joël Wilfried Gumede, Nicksy Vignuzzi, Marco Bessaud, Maël Gouandjika-Vasilache, Ionela Vaccine-Derived Polioviruses, Central African Republic, 2019 |
title | Vaccine-Derived Polioviruses, Central African Republic, 2019 |
title_full | Vaccine-Derived Polioviruses, Central African Republic, 2019 |
title_fullStr | Vaccine-Derived Polioviruses, Central African Republic, 2019 |
title_full_unstemmed | Vaccine-Derived Polioviruses, Central African Republic, 2019 |
title_short | Vaccine-Derived Polioviruses, Central African Republic, 2019 |
title_sort | vaccine-derived polioviruses, central african republic, 2019 |
topic | Dispatch |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853572/ https://www.ncbi.nlm.nih.gov/pubmed/33496226 http://dx.doi.org/10.3201/eid2702.203173 |
work_keys_str_mv | AT joffretmarieline vaccinederivedpoliovirusescentralafricanrepublic2019 AT dotejoelwilfried vaccinederivedpoliovirusescentralafricanrepublic2019 AT gumedenicksy vaccinederivedpoliovirusescentralafricanrepublic2019 AT vignuzzimarco vaccinederivedpoliovirusescentralafricanrepublic2019 AT bessaudmael vaccinederivedpoliovirusescentralafricanrepublic2019 AT gouandjikavasilacheionela vaccinederivedpoliovirusescentralafricanrepublic2019 |